FoldRx Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

FoldRx Pharmaceuticals Ownership

Who owns FoldRx Pharmaceuticals?

FoldRx Pharmaceuticals is owned by Pfizer. It was acquired on October 6, 2010.

Was FoldRx Pharmaceuticals formerly PE-backed?

Yes. FoldRx Pharmaceuticals was formerly owned by 4 private investors.

FoldRx Pharmaceuticals Business Overview

Where is FoldRx Pharmaceuticals headquartered?

FoldRx Pharmaceuticals is headquartered in Cambridge, Massachusetts.

What sector is FoldRx Pharmaceuticals in?

FoldRx Pharmaceuticals is a life science company.

When was FoldRx Pharmaceuticals founded?

FoldRx Pharmaceuticals was founded in 2003.

Life Science M&A Summary in 2010

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010. The largest life science acquisition in 2010 was Solvay Pharmaceuticals - which was acquired by Abbott Laboratories for $6.1B.

Join Mergr to view all 138 acquisitions of life science companies in 2010, including 15 acquisitions by private equity firms, and 123 by strategics.

FoldRx Pharmaceuticals

FoldRx Pharmaceuticals, Inc

100 Acorn Park Drive, 5th Floor,
Cambridge, Massachusetts 02140
United States,
(617) 252-5500
www.foldrx.com

FoldRx Pharmaceuticals is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis). The Company's lead product, FX-4006, has begun a Phase II/III study in familial amyloid polyneuropathy. FoldRx Pharmaceuticals was founded in 2003 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 206,651
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.